Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole and Sensorimotor Function in Stuttering
NCT07215884Phase 1Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in stuttering comparing Single dose of aripiprazole with Placebo dose (2 arms). Primary endpoints: Pre-speech auditory modulation, Speaking Induced Suppression and 2 more. Started Sep 2025; status: recruiting.
02
Drugs
aripiprazole
03
Conditions
stuttering
Beyond the preview
Go deeper on NCT07215884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215884.